Home

Holly Randall is all natural. How long will she stay that way?

Here's a report from PlasticSurgery.org about face transplants. The risks may not be as high as once said:

ARLINGTON HEIGHTS, Ill. – Face transplants, once on the fringe of medicine, may eventually become more mainstream because of new estimates that suggest the risk of tissue rejection might be lower than previously thought, according to a recent review in Plastic and Reconstructive Surgery® (PRS), the official medical journal of the American Society of Plastic Surgeons (ASPS). “We can only know the true immunological risks associated with face transplants by carefully observing those who have already had the procedure,” said ASPS President Roxanne Guy, MD. “While this paper doesn’t provide conclusive evidence of the immunological risks, it will help us move forward in making face transplants part of mainstream medicine.” Currently, immunosuppressive drugs are the biggest barrier the medical community faces in performing any transplant because the potential long-term side effects of these medications can make the risk too great.